Company registration number 06707187 (England and Wales)
CRITICAL CARE CONSULT LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
CRITICAL CARE CONSULT LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2
Notes to the financial statements
3 - 6
CRITICAL CARE CONSULT LIMITED
ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF CRITICAL CARE CONSULT LIMITED FOR THE YEAR ENDED 31 JULY 2025
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Critical Care Consult Limited for the year ended 31 July 2025 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the b oard of d irectors of Critical Care Consult Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Critical Care Consult Limited and state those matters that we have agreed to state to the b oard of d irectors of Critical Care Consult Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Critical Care Consult Limited and its b oard of d irectors as a body, for our work or for this report.

It is your duty to ensure that Critical Care Consult Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Critical Care Consult Limited. You consider that Critical Care Consult Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Critical Care Consult Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory f inancial statements.

Xeinadin South East Limited
2 High Street
Burnham on Crouch
Essex
CM0 8AA
15 April 2026
CRITICAL CARE CONSULT LIMITED
BALANCE SHEET
AS AT
31 JULY 2025
31 July 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
439,766
449,539
Current assets
Debtors
4
1,647,582
1,622,381
Investments
5
228,672
200,085
Cash at bank and in hand
137,555
108,617
2,013,809
1,931,083
Creditors: amounts falling due within one year
6
(114,204)
(107,560)
Net current assets
1,899,605
1,823,523
Total assets less current liabilities
2,339,371
2,273,062
Creditors: amounts falling due after more than one year
7
(1,667)
(11,667)
Net assets
2,337,704
2,261,395
Capital and reserves
Called up share capital
3
2
Profit and loss reserves
2,337,701
2,261,393
Total equity
2,337,704
2,261,395

For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 15 April 2026
Dr U Waheed
Director
Company registration number 06707187 (England and Wales)
CRITICAL CARE CONSULT LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
- 3 -
1
Accounting policies
Company information

Critical Care Consult Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2 High Street, Burnham on Crouch, Essex, England, CM0 8AA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

CRITICAL CARE CONSULT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 4 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.6
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

CRITICAL CARE CONSULT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
3
Tangible fixed assets
Land and buildings
£
Cost
At 1 August 2024 and 31 July 2025
488,630
Depreciation and impairment
At 1 August 2024
39,091
Depreciation charged in the year
9,773
At 31 July 2025
48,864
Carrying amount
At 31 July 2025
439,766
At 31 July 2024
449,539
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
31,744
16,543
Other debtors
1,615,838
1,605,838
1,647,582
1,622,381
5
Current asset investments
2025
2024
£
£
Other investments
228,672
200,085
CRITICAL CARE CONSULT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 6 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
10,000
10,000
Trade creditors
-
0
174
Taxation and social security
38,717
30,823
Other creditors
65,487
66,563
114,204
107,560
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
1,667
11,667
8
RELATED PARTY DISCLOSURES

During the course of the year the company has advanced money to an associated company, Critical Care Consult (2016) Limited, amounting to £10,000 (202 4 £33,000). At the balance sheet date there was an amount due to the company by Critical Care Consult (2016) Limited of £1,615,838 (202 4 £1,605,838).

2025-07-31 2024-08-01 false false false 15 April 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr U Waheed 06707187 2024-08-01 2025-07-31 06707187 2025-07-31 06707187 2024-07-31 06707187 core:LandBuildings 2025-07-31 06707187 core:LandBuildings 2024-07-31 06707187 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 06707187 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 06707187 core:WithinOneYear 2025-07-31 06707187 core:WithinOneYear 2024-07-31 06707187 core:AfterOneYear 2025-07-31 06707187 core:AfterOneYear 2024-07-31 06707187 core:CurrentFinancialInstruments 2025-07-31 06707187 core:CurrentFinancialInstruments 2024-07-31 06707187 core:ShareCapital 2025-07-31 06707187 core:ShareCapital 2024-07-31 06707187 core:RetainedEarningsAccumulatedLosses 2025-07-31 06707187 core:RetainedEarningsAccumulatedLosses 2024-07-31 06707187 bus:Director1 2024-08-01 2025-07-31 06707187 core:LandBuildings core:OwnedOrFreeholdAssets 2024-08-01 2025-07-31 06707187 2023-08-01 2024-07-31 06707187 core:LandBuildings 2024-07-31 06707187 core:LandBuildings 2024-08-01 2025-07-31 06707187 core:Non-currentFinancialInstruments 2025-07-31 06707187 core:Non-currentFinancialInstruments 2024-07-31 06707187 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 06707187 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 06707187 bus:FRS102 2024-08-01 2025-07-31 06707187 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 06707187 bus:FullAccounts 2024-08-01 2025-07-31 xbrli:pure xbrli:shares iso4217:GBP